Association of dietary inflammatory index with all-cause and cardiovascular disease mortality in hyperuricemia population: A cohort study from NHANES 2001 to 2010

Jingda Huang,Yandong Zhang,Jiajie Li,Huimin Li,Yihui Wei,Mindan Sun

DOI: https://doi.org/10.1097/md.0000000000036300

IF: 1.6

2023-12-23

Medicine

Abstract:Hyperuricemia is a metabolic disorder resulting from prolonged dysfunction in purine metabolism, excessive purine intake, or impaired elimination of uric acid. In the nationally representative sample survey conducted in 2015 to 2016, the occurrence rate of hyperuricemia among adult individuals in the United States was recorded at 20%, and this prevalence remained stable over a period of 10 years. [ 1 ] In China, data from 2018 to 2019 indicated an overall prevalence of hyperuricemia among the adult population at 14%, with a significantly higher prevalence among males (24.4%) compared to females (3.6%). Furthermore, there has been an upward trend in the overall prevalence of hyperuricemia within a span of 5 years in China. [ 2 ] Chronic hyperuricemia leads to the deposition of urate crystals in joints and surrounding soft tissues, resulting in recurrent episodes of acute joint and soft tissue inflammation, commonly known as gout. [ 3 ] Recent epidemiological studies have also found that cumulative exposure to elevated blood uric acid levels may be associated with elevated morbidity of non-articular conditions such as stroke, cardiovascular events, chronic kidney disease, liver disease and metabolic syndrome. [ 4–8 ] Furthermore, it has been observed that there exists a positive correlation between hyperuricemia and elevated increased all-cause mortality in the general population, as well as in specific populations such as individuals with diabetes, chronic heart failure, chronic kidney disease, and metabolic dysfunction-associated fatty liver disease (MAFLD). [ 4 , 5 , 9–11 ] Therefore, the threat posed by hyperuricemia to public health is highly intricate and may potentially surpass people conventional estimations. In studies conducted, a positive correlation has been observed between white blood cell count and the prevalence of hyperuricemia in individuals without underlying diseases. Additionally, individuals with hyperuricemia have shown significant elevations in serum levels of C-reactive protein (CRP), tumor necrosis factor (TNF), interleukin-6 (IL-6), and other inflammatory mediators. [ 12 ] In recent years, mechanistic studies have revealed that the NF-κB pathway is a key pathway involved in the induction of inflammation by uric acid crystals. [ 13 ] This implies that inflammation could potentially exert a substantial influence on the pathological process of hyperuricemia.

medicine, general & internal